Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K J Scanlon

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1987
The role of methionine in methotrexate-sensitive and methotrexate-resistant mouse leukemia L1210 cellsK J Scanlon, M Kashani-Sabet, A R Cashmore, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1991
Ribozyme-mediated cleavage of c-fos mRNA reduces gene expression of DNA synthesis enzymes and metallothioneinK J Scanlon, L Jiao, T Funato, et al.
Cancer Gene Therapy|August 20, 2005
Growth inhibition efficacy of an adenovirus expressing dual therapeutic genes, wild-type p53, and anti-erbB2 ribozyme, against human bladder cancer cellsA Irie, K Matsumoto, B Anderegg, et al.
Cancer Research|October 15, 1988
Detection of drug resistance in human tumors by in vitro enzymatic amplificationM Kashani-Sabet, J J Rossi, Y Lu, et al.
Cancer Research|April 1, 1985
Evolution of methotrexate resistance of human acute lymphoblastic leukemia cells in vitroT Ohnuma, R J Lo, K J Scanlon, et al.
International Journal of Cancer|July 10, 1999
Altered expression of mRNAs for apoptosis-modulating proteins in a low level multidrug resistant variant of a human lung carcinoma cell line that also expresses mdr1 mRNAR NicAmhlaoibh, M Heenan, I Cleary, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Inhibition of methionine uptake by methotrexate in mouse leukemia L1210 cellsK J Scanlon, A R Cashmore, M Kashani-Sabet, et al.
Cancer Gene Therapy|November 1, 2001
Hammerhead ribozyme against gamma-glutamylcysteine synthetase sensitizes human colonic cancer cells to cisplatin by down-regulating both the glutathione synthesis and the expression of multidrug resistance proteinsT Iida, H Kijima, Y Urata, et al.
Biochemical and Biophysical Research Communications|July 2, 1998
Hammerhead ribozymes against gamma-glutamylcysteine synthetase mRNA down-regulate intracellular glutathione concentration of mouse islet cellsH Kijima, T Tsuchida, H Kondo, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Deficient repair of cisplatin-DNA adducts identified in human testicular teratoma cell lines established from tumours from untreated patientsB T Hill, K J Scanlon, J Hansson, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Cancer Chemotherapy and Pharmacology|January 1, 1987
The role of methionine in methotrexate-sensitive and methotrexate-resistant mouse leukemia L1210 cellsK J Scanlon, M Kashani-Sabet, A R Cashmore, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1991
Ribozyme-mediated cleavage of c-fos mRNA reduces gene expression of DNA synthesis enzymes and metallothioneinK J Scanlon, L Jiao, T Funato, et al.
Cancer Gene Therapy|August 20, 2005
Growth inhibition efficacy of an adenovirus expressing dual therapeutic genes, wild-type p53, and anti-erbB2 ribozyme, against human bladder cancer cellsA Irie, K Matsumoto, B Anderegg, et al.
Cancer Research|October 15, 1988
Detection of drug resistance in human tumors by in vitro enzymatic amplificationM Kashani-Sabet, J J Rossi, Y Lu, et al.
Cancer Research|April 1, 1985
Evolution of methotrexate resistance of human acute lymphoblastic leukemia cells in vitroT Ohnuma, R J Lo, K J Scanlon, et al.
International Journal of Cancer|July 10, 1999
Altered expression of mRNAs for apoptosis-modulating proteins in a low level multidrug resistant variant of a human lung carcinoma cell line that also expresses mdr1 mRNAR NicAmhlaoibh, M Heenan, I Cleary, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Inhibition of methionine uptake by methotrexate in mouse leukemia L1210 cellsK J Scanlon, A R Cashmore, M Kashani-Sabet, et al.
Cancer Gene Therapy|November 1, 2001
Hammerhead ribozyme against gamma-glutamylcysteine synthetase sensitizes human colonic cancer cells to cisplatin by down-regulating both the glutathione synthesis and the expression of multidrug resistance proteinsT Iida, H Kijima, Y Urata, et al.
Biochemical and Biophysical Research Communications|July 2, 1998
Hammerhead ribozymes against gamma-glutamylcysteine synthetase mRNA down-regulate intracellular glutathione concentration of mouse islet cellsH Kijima, T Tsuchida, H Kondo, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Deficient repair of cisplatin-DNA adducts identified in human testicular teratoma cell lines established from tumours from untreated patientsB T Hill, K J Scanlon, J Hansson, et al.
Pageof 9